Clifford B. Jones, BSc MSc MB ChB

Global medical lead
ViiV Healthcare, Brentford, UK, United Kingdom

Disclosure(s): GSK: Stocks/Bonds; viiv healthcare: Employee

Poster(s):

• 1267 - Efficacy and Safety of Switching to DTG/3TC in Virologically Suppressed PLWH by Age, Including Those Aged ≥65 Years: Pooled Results from the TANGO and SALSA Studies
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET

• 1285 - Systematic Literature Review of Real-world Experience with the 2-Drug Regimen Dolutegravir and Lamivudine in People with HIV Who Would Not Have Met Inclusion Criteria for the Phase 3 Clinical Program
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET